AAFCO Compliant Cat Food Manufacturer: What Buyers Need to Know

Cats are obligate carnivores with genuinely different nutritional requirements than dogs, and AAFCO publishes separate nutrient profiles for cats reflecting this — notably higher protein requirements and an absolute requirement for taurine, an amino acid cats cannot synthesise in sufficient quantities and must obtain from diet. A manufacturer formulating cat food needs specific cat nutrition expertise, not just general pet food formulation experience adapted from dog food.

Taurine deficiency in cats can cause serious health issues, which is why AAFCO's cat nutrient profiles specify minimum taurine levels distinctly from dog profiles. Other cat-specific considerations include arachidonic acid (an essential fatty acid cats can't synthesise like dogs can) and vitamin A (cats can't convert beta-carotene to vitamin A the way dogs and other species can, so it must be supplied directly). Verify a manufacturer's formulation addresses these explicitly rather than assuming a dog food formulation approach transfers directly. A manufacturer with strong dog food AAFCO experience but limited cat food production history should be asked directly about their cat-specific formulation track record before being trusted with a cat food programme.

As with dog food, AAFCO publishes distinct nutrient profiles for growth/reproduction, adult maintenance, and all-life-stages cat food formulations. A manufacturer should specify which life stage profile a given formulation meets and provide nutrient analysis documentation to support it as standard practice. Confirm this documentation matches your intended packaging claims before finalising label artwork, since a mismatch discovered post-production is costly to correct.

Cat food, like dog food, can meet AAFCO requirements either through formulation to published nutrient profiles (verified by laboratory analysis) or through AAFCO feeding trial protocols involving actual feeding studies. Formulation-based substantiation is faster and less costly; feeding trials are more rigorous and often used to support premium or functional claims like urinary health formulations. Buyers positioning a range around a functional health claim should lean toward manufacturers offering feeding-trial substantiation, since it carries more weight with retail buyers evaluating competing functional claims on shelf.

Cat food labelling compliance covers the same general AAFCO-aligned requirements as dog food (ingredient ordering, guaranteed analysis, feeding guidelines) plus scrutiny around cat-specific functional claims — urinary health, hairball control, and similar claims need appropriate formulation backing, not just packaging language, to avoid misleading-claim issues.

As with dog food, AAFCO (US) and FEDIAF (EU) cat food nutrient guidelines are broadly similar in intent but not identical documents. Buyers targeting both markets should have formulations reviewed against both standards separately rather than assuming compliance with one covers the other. Budgeting for dual-market formulation review upfront is generally cheaper than discovering a compliance gap after a formulation is already in production for one market and needs rework for the other.

Beyond the general AAFCO documentation mistakes that apply to any pet food category, cat food buyers most often run into trouble by assuming a dog food manufacturer's general pet food certification automatically covers cat-specific formulation competency (taurine dosing and urinary pH management require distinct expertise), and by not confirming functional claim substantiation (urinary health, hairball control) separately from base nutrient adequacy compliance. Ask specifically about the manufacturer's cat food formulation track record, not just their general AAFCO compliance history.

Candora Petcare works with certified factory partners experienced in AAFCO-compliant cat food formulation — including taurine and other cat-specific nutrient requirements — and supports documentation and US label compliance as part of every US-market programme. We can also coordinate parallel FEDIAF review for buyers planning to launch the same range into EU markets, so a single formulation review process covers both regulatory paths instead of two separate engagements later.